“Must-Read” review from BiotechIntel Novo Nordisk – the world’s largest insulin producer – and major diabetes drug manufacturers – could see BILLIONS in recurring revenue dry up as a small, California-based biotech company advances a technology that promises to change diabetes treatment. Over $100,000,000 has been invested in developing this super-drug that threatens to make […]
Home» Posts tagged "AntriaBio"
Mid-Term Investment Opportunity with AntriaBio (ANTB)
edited on 02/02/2013: AntriaBio, Inc. (“AntriaBio”) announced that FINRA has approved a change of the Company’s stock ticker symbol. Effective today, the Company’s common shares will commence trading on the OTC Bulletin Board under the trading symbol “ANTB” ( OTCQB : ANTB ). The previous trading symbol was “FMYY” ( OTCQB : FMYY ). AntriaBio, […]